Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sodium stibogluconate (Pentostam) | Drug | 20 mg/kg IV every day for 20 or 28 days |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Brian Schwartz, MD | University of CA at San Francisco | Principal Investigator |
| Kanade Shinkai, MD | University of CA at San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of CA at San Francisco Hospitals and Clinics | San Francisco | California | 94143 | United States |
Not provided
| ID | Term |
|---|---|
| D016773 | Leishmaniasis, Cutaneous |
| D007897 | Leishmaniasis, Mucocutaneous |
| ID | Term |
|---|---|
| D007896 | Leishmaniasis |
| D056986 | Euglenozoa Infections |
| D011528 | Protozoan Infections |
| D010272 | Parasitic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000967 | Antimony Sodium Gluconate |
| ID | Term |
|---|---|
| D009930 | Organic Chemicals |
| D005942 | Gluconates |
| D013400 | Sugar Acids |
| D000144 | Acids, Acyclic |
Not provided
Not provided
| D007239 |
| Infections |
| D012876 | Skin Diseases, Parasitic |
| D000079426 | Vector Borne Diseases |
| D012874 | Skin Diseases, Infectious |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D002264 |
| Carboxylic Acids |
| D006880 | Hydroxy Acids |
| D002241 | Carbohydrates |